Market Signal Briefing

LOS ANGELES, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Inspire repeatedly assured investors that it was fully prepared for every aspect of the Inspire V launch, touting high demand in the market. In truth, the Company’s Inspire V launch was disastrous and was met with weak demand. The Company ignored basic steps that help ensure the quick adoption of new devices by clinicians. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Inspire, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

 The Schall Law Firm

By

:

Published: Dec 5, 2025, 14:30 GMT+00:00

Several major stocks were active in pre-market trading on Friday, with Warner Bros. Discovery jumping on talks to sell studio assets to Netflix, Netflix edging lower amid its downtrend and large potential outlay, and Amazon holding steady near key moving averages.

WBD Technical Analysis
Warner Bros. Discovery is strong in pre-market trading as it is in negotiations with Netflix to sell some of its studio properties. HBO Max and its studios are being thought of as being sold for 72 billion or $27.75 a share. So, in other words, it should continue to see a bit of bullish pressure due to the unlocked value. Short-term pullbacks, if you get them, should be buying opportunities.

NFLX Technical Analysis
Netflix looks like it is drifting a little bit lower, but that would make sense considering that it is in a downtrend anyway over the last several weeks. And of course, an outlay of $72 billion does take cash off the balance sheet. Does this end up being a longer-term negative? I doubt it. I think it actually makes quite a bit of sense, considering that Netflix has been producing its own material for a while.

So it just makes sense that this move happens. And at the end of the day, this should end up being a buying opportunity with Netflix recently splitting its shares. But now we find ourselves near the $100 level in pre-market trading. So that could come into play as well from the psychological standpoint.

AMZN Technical Analysis
Amazon looks like it is going to be right about where it was when it closed. Pre-market trading’s up by about 20 cents or so, as we’re hanging around the 50-day EMA. Amazon should be making a lot of money this time of year. And I think a lot of people are probably going to give it the benefit of the doubt. I think if we rally from here, the $240 level is a significant amount of resistance. But if we can break there, then I think that Amazon goes looking to the $260 level.

Short-term pullbacks at this point in time should continue to see support near the 200-day EMA and then again at the $210 level. So, I think there are plenty of buying on the dip opportunities just waiting to happen in Amazon.

For a look at all of today’s economic events, check out our economic calendar.

Related Articles

NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Continue to See Buying EarlyThe “Secret Sauce” to Monster GainsSee How Analog Devices Attracts Huge Institutional Inflows

Chris is a proprietary trader with more than 20 years of experience across various markets, including currencies, indices and commodities. As a senior analyst at FXEmpire since the website’s early days, he offers readers advanced market perspectives to navigate today’s financial landscape with confidence.

Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.

Initial development completed at New Rise Reno 2, advancing XCF's second SAF production facility and positioning construction to begin in 2026.

$300 million planned investment will double XCF's total SAF production capacity to ~80 million gallons annually, positioning New Rise Reno as a major U.S. SAF production center.

Global demand accelerates as mandates tighten, creating one of the strongest growth opportunities in renewable fuels - one that XCF's modular SAF platform is positioned to capture.

HOUSTON, TX / ACCESS Newswire / December 5, 2025 / XCF Global, Inc. ("XCF") (Nasdaq:SAFX), a key player in decarbonizing the aviation industry through Sustainable Aviation Fuel ("SAF"), today announced new development milestones at its New Rise Reno 2 site, the Company's second SAF production facility and the next deployment of its scalable, modular production platform.

XCF has completed initial site work at New Rise Reno 2, including grading of the 10-acre parcel and construction of new access roads. Engineering, design, and project planning are underway, positioning construction to begin in 2026.

Located adjacent to the existing New Rise Reno facility in Nevada, the new site will benefit from integration with common facilities such as gas, water, rail, and personnel offices as well as existing pre-treatment, hydrogen production, and broader logistics infrastructure - reducing capital costs, lowering execution risk, and accelerating time to production.

Since inception, approximately $350 million has been invested in XCF's flagship New Rise Reno facility. New Rise Reno 2 represents the next phase of this growth strategy, with an expected $300 million investment enabling XCF to double SAF production capacity to ~80 million gallons annually.

Chris Cooper, CEO of XCF Global, commented:

"New Rise Reno 2 is the next leap forward in our growth strategy. By adding a second, fully integrated facility, we're turning New Rise Reno intoa major U.S. SAF production center and positioning XCF for sustained, long-term growth. This expansion exemplifies how XCF grows: intentionally, efficiently, and with a platform built to meet surging global demand."

Rendering of New Rise Reno 2Expanding Global Reach

The development of New Rise Reno 2 strengthens XCF's ability to meet rising SAF demand across the world's most important aviation markets. In November, XCF signed a Memorandum of Understanding ("MOU") with BGN INT US LLC ("BGN"), a global energy and commodities group, to jointly develop global distribution, marketing, and offtake frameworks across Europe, the Middle East, and other strategic markets.

The partnership would connect XCF's expanding production capacity with BGN's global logistics and trading network, creating an integrated supply chain from feedstock to finished fuel.

This strategic alignment comes as demand accelerates across major aviation markets.

U.S. SAF Grand Challenge: Federal targets call for 3 billion gallons of SAF per year by 2030 and 35 billion gallons to satisfy 100% of domestic demand by 2050; however, current U.S. production remains below 1% of jet fuel demand.

ReFuelEU Aviation Mandates: Airlines will be required to blend 2% SAF in 2025, increasing to 6% by 2030, and 20% by 2035, ultimately rising to 70% by 2050. With regional supply unable to meet these mandated volumes, Europe is expected to face structural shortages and persistently elevated SAF pricing.

Together, the U.S. and Europe represent one of the largest and fastest-growing opportunities in the clean-energy transition, with the U.S. SAF market projected to reach nearly $7 billion by 2030 and global demand exceeding $25 billion. XCF's scalable, modular SAF platform is built to scale directly into this opportunity.

XCF will continue to provide updates as development progresses.

About XCF Global, Inc.

XCF Global, Inc. ("XCF") is a pioneering sustainable aviation fuel company dedicated to accelerating the aviation industry's transition to net-zero emissions. Our flagship facility, New Rise Reno, has a nameplate production capacity of 38 million gallons per year, positioning XCF as an early mover among large-scale SAF producers in North America. XCF is advancing a pipeline of three additional sites in Nevada, North Carolina, and Florida, and is building partnerships across the energy and transportation sectors to scale SAF globally. XCF is listed on the Nasdaq Capital Market and trades under the ticker, SAFX. Current outstanding shares: ~208.3 million; <20% free float (as of December 5, 2025).

To learn more, visit www.xcf.global.

Contacts

XCF Global:
C/O Camarco
[email protected]

Media:

Camarco

Andrew Archer | Rosie Driscoll | Violet Wilson

[email protected]

Forward-Looking Statements

This Press Release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expect", "intend", "will", "estimate", "anticipate", "believe", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global's expectations with respect to future performance and anticipated financial impacts of the recently completed business combination with Focus Impact BH3 Acquisition Company (the "Business Combination"), estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global's expenses, including manufacturing and operating expenses and interest expenses, as a result of potential inflationary pressures, changes in interest rates and other factors; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global's offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination or others; (5) XCF Global's ability to regain compliance with Nasdaq's continued listing standards and thereafter continue to meet Nasdaq's continued listing standards; (6) XCF Global's ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global's ability to raise financing to fund its operations and business plan and the terms of any such financing; (8) the New Rise Reno production facility's ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) the New Rise Reno production facility's ability to produce renewable diesel in commercial quantities without interruption during the ongoing SAF ramp-up process; (10) XCF Global's ability to resolve current disputes between its New Rise subsidiary and its landlord with respect to the ground lease for the New Rise Reno facility; (11) XCF Global's ability to resolve current disputes between its New Rise subsidiary and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (12) payment of fees, expenses and other costs related to the completion of the Business Combination and the New Rise acquisitions; (13) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (14) XCF Global's ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (15) changes in applicable laws or regulations; (16) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (17) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (18) the availability of tax credits and other federal, state or local government support; (19) risks relating to XCF Global's and New Rise's key intellectual property rights, including the possible infringement of their intellectual property rights by third parties; (20) the risk that XCF Global's reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (21) LOIs and MOUs may not advance to definitive agreements or commercial deployment; (22) the effects of increased costs associated with operating as a public company; and (23) various factors beyond management's control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global's filings with the Securities and Exchange Commission ("SEC"), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global made or will make with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global's expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global's assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.

SOURCE: XCF Global, Inc.

Key Takeaways
Netflix said Friday it agreed to acquire Warner Bros. Discovery in an $83 billion deal.Warner Bros. Discovery still plans to split its cable TV channels like CNN and TBS off into a standalone company before its TV and movie studios and streaming services are acquired by Netflix.

The bidding war for Warner Bros. Discovery (WBD) is officially over, as the entertainment giant and Netflix (NFLX) announced an $83 billion deal Friday.

Warner Bros. Discovery plans to continue with its previously planned break-up, which will involve spinning off its cable TV channels including CNN and TBS into a standalone business, leaving the remaining studios that make TV and movies and the company's streaming services to be acquired by Netflix for $27.75 per share. The companies expect the deal to close in the third quarter of next year.

Netflix co-CEO Ted Sarandos said Friday that combining with Warner Bros. Discovery will help both companies "define the next century of storytelling."

Warner Bros. Discovery shares were little changed in premarket trading Friday, while Netflix shares fell 3.5% following the announcement.

Why This Is Significant
Netflix acquiring Warner Bros. Discovery could reshape the streaming landscape, as the company will own both its namesake service and HBO Max. The deal would give Netflix even more influence in a streaming industry already dominated by a small number of firms.

Late Thursday night, reports emerged that Netflix and Warner Bros. Discovery had entered exclusive deal talks, with competing bidders Paramount Skydance (PSKY) and Comcast (CMCSA) looking to be out of the running.

The bidding war started earlier this year, when Paramount started to make offers to acquire all of Warner Bros. Discovery after the company completed its own merger with Skydance, owned by the Ellison family. Netflix and Comcast entered the running later.

Now, the deal could face regulatory scrutiny over whether it would make Netflix too dominant a player in streaming. Paramount has reportedly argued that the industry would become too consolidated by Netflix's win.

Do you have a news tip for Investopedia reporters? Please email us at

[email protected]

Key Takeaways Marvell Technology reported Q3 revenues of $2.08B, driven by data center, networking and carrier gains.Data center sales rose 37.8% to $1.52B, supported by custom XPU silicon and electro-optic products.The Celestial AI acquisition aims to strengthen Marvell Technology in next-gen optical interconnects.
Marvell Technology Inc. (MRVL - Free Report) — a leading fabless designer, developer and marketer of analog, mixed-signal and digital signal processing integrated circuits for artificial intelligence AI) infrastructure — reported strong third-quarter fiscal 2026 earnings results. Quarterly EPS of $0.76 per share,, beat the Zacks Consensus Estimate by 1.3%. Total revenues of $2.08 billion surpassed the Zacks Consensus Estimate by 0.61%.

MRVL is a promising player in the solid-state drive controllers’ market. The storage market is seeing a steady increase in demand, given the fast-growing data volume, especially the exponential growth in unstructured data. Completion of inventory digestions is likely to aid growth for MRVL across the enterprise networking and carrier infrastructure end markets.

Solid Business GrowthThird-quarter revenues grew 36.8% year over year, mainly driven by strong growth in the data center and continued recovery in enterprise networking and carrier infrastructure end markets. 

Data center revenues of $1.52 billion increased 37.8% year over year and 1.8% sequentially, driven by strong traction in custom XPU silicon, electro-optic interconnect products and next-generation switch offerings. The segment contributed 73.2% of total revenues, reaffirming its position as MRVL’s largest end market.

Revenues from enterprise networking rose 57% year over year and 23% sequentially to $237.2 million, accounting for 11.4% of total revenues. The robust growth primarily reflected the continued normalization of inventory levels.

Carrier infrastructure revenues increased 98% year over year and 29% sequentially to $167.8 million, representing 8.1% of total revenues, driven by demand recovery across carrier customers.

Custom AI silicon and electro-optics products have positioned MRVL as a critical player in high-performance computing. The company’s partnerships with leading hyperscalers ensure sustained growth, with management confident that revenues from its custom XPU (accelerated computing) solutions will continue expanding in fiscal 2027 and beyond.

Expansion Through AcquisitionMRVL announced the acquisition (expected to close in the first quarter of fiscal 2027) of Celestial AI, which specializes in the Photonic Fabric technology platform. This platform is purpose-built for scale-up optical interconnect.

MRVL highlighted that Celestial AI is “deeply engaged” with several hyperscalers and ecosystem partners. Celestial AI has already won a major contract with one of the biggest hyperscalers. This hyperscaler intends to use the photonic fabric chiplets in its next-generation scale-up architecture. 

Hyperscalers are also central to the company’s other product lines. MRVL is pushing boundaries with 400G per lane PAM technology, enabling 3.2T optical interconnects and future-proofing hyperscaler infrastructure.

Acquisition of Celestial AI will put Marvell on a firm footing in the next-generation energy-efficient AI infrastructure space to compete intensely with bigwigs like NVIDIA Corp. (NVDA - Free Report) and Broadcom Inc. (AVGO - Free Report) . 

Strong Guidance MRVL provided strong revenue guidance for the fourth quarter. It expects revenues to be $2.20 billion (+/- 5%). The Zacks Consensus Estimate for revenues is pegged at $2.15 billion, implying 18.52% year-over-year improvement. Marvell expects data center revenue growth to be higher next year, reflecting accelerating AI demand.

The company projects non-GAAP earnings per share for the fiscal fourth quarter to be $0.79 (+/- $0.05). The Zacks Consensus Estimate for revenues is pegged at $0.78, implying 30% year-over-year improvement.

Attractive Estimate RevisionsMRVL has an expected revenue and earnings growth rate of 15.3% and 18.9%, respectively, for next year (ending January 2027). The Zacks Consensus Estimate for next year’s earnings has improved 0.6% in the last 30 days. 

Marvell currently carries a marvelous long-term (3-5 years) EPS growth rate of 38.2% compared with the broad-market index — the S&P 500 — long-term growth rate of 16.1%. 

Image Source: Zacks Investment Research

Excellent ValuationMarvell Technology currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Year to date, the stock price of Marvell Technology has been going through a rough patch. The stock price has fallen more than 11% in 2025. The stock is currently trading at a 21.4% discount to its 52-week high. MRVL currently carries a forward P/E of 32.8% compared with 34% of its peers’ average. Return on equity is 15.2% compared with 2.9% of the industry. 

Image Source: Zacks Investment Research

Strong growth in MRVL’s data center, enterprise networking and carrier infrastructure revenues coupled with the proposed acquisition of Celestial AI could be a game changer for the company. Consequently, the stock could be a potential dark horse in Wall Street’s AI infrastructure race.

Image Source: Zacks Investment Research

Key Takeaways Omnicell is seeing momentum from its SaaS and Expert Services offerings and new launches.
OMCL targets overseas markets where medication control adoption remains minimal.
Omnicell ended Q3 2025 with more cash than debt, reflecting a stable solvency position.

Omnicell’s (OMCL - Free Report) strength in its SaaS and Expert Services offerings should help sustain growth in the upcoming quarters. Efforts to expand into overseas markets instill optimism. Additionally, a stable solvency looks encouraging. However, fierce rival pressure could hurt Omnicell’s performance.

Omnicell, carrying a Zacks Rank #2 (Buy) at present, has gained 27.8% against the industry's 9.7% decline over the past year. The S&P 500 composite has increased 17.1% in the said time frame.

The renowned healthcare technology company has a market capitalization of $1.82 billion. Omnicell’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 38.7%.

Tailwinds for OMCL StockRobust Pipeline for SaaS and Expert Services Portfolio: Omnicell’s suite of SaaS and Expert Services includes a combination of robotics, smart devices, intelligent software and expert services. These subscription-based offerings are a key part of the company’s medication management infrastructure to help drive improved clinical, operational and financial outcomes across all care settings.

In late 2024, Omnicell announced OmniSphere, a next-generation, cloud native, software workflow engine and data platform that is intended to seamlessly integrate enterprise-wide robotics and smart devices to support more secure, data-driven, medication management across the continuum of care. OmniSphere recently became HITRUST CSF (Common Security Framework) i1 certified. Additionally, the company introduced Central Med Automation Service, a subscription-based solution designed to help health systems establish and continuously optimize centralized medication management for consolidated pharmacy services centers and similar operations.

Omnicell also offers 340B solutions, which are related to the federal 340B Drug Pricing Program, requiring pharmaceutical manufacturers participating in Medicaid to sell covered outpatient drugs at discounted prices to specified healthcare organizations (called 340B covered entities).

Planned Geographic Expansion Another Upside: Outside the United States, healthcare providers are becoming increasingly aware of the benefits of automation. Many government and private entities are aware of the progress made over the last several years in the United States and are investing significantly in information technology and automation.

The company’s international operations include its sales efforts centered in Canada, Europe, the Middle East, and the Asia-Pacific regions and supply-chain efforts in Asia. Given the fact that the international market is less than 1% penetrated with very few hospitals adopting medication control systems, Omnicell intends to expand into new markets, which it views as strategic.

Image Source: Zacks Investment Research

Strong Liquidity and Capital Structure: Omnicell exited the third quarter of 2025 with cash and cash equivalents of $180 million, higher than its $167 million total debt on the balance sheet. This is indicative of a sound solvency position. The total debt to capital ratio was 12.1x in the third quarter, down from 21.3x in the previous quarter.

Concerns for OMCL Competitive Landscape: Omnicell faces intense competition in the medication management and supply-chain solutions market. Even though the company continues to gain market share from other traditional providers of medication management and supply-chain solutions, major players pose threats as they spearhead several expansion programs. This increased competition could result in pricing pressure and a reduced margin, negatively affecting the company’s performance.

OMCL Estimate TrendThe Zacks Consensus Estimate for 2025 earnings per share has moved north 8.3% to $1.70 in the past 30 days. 

The consensus mark for 2025 revenues is pegged at $1.19 billion, indicating a 6.5% rise from the year-ago reported number.

Other Key PicksSome other top-ranked stocks in the broader medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , Phibro Animal Health (PAHC - Free Report) and Cardinal Health (CAH - Free Report) . 

BrightSpring Health Services has an estimated earnings growth rate of 100% for fiscal 2026 compared with the S&P 500 composite’s 16.7%. Shares of the company have rallied 101.1% compared with the industry’s 3% growth. BTSG’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 45.1%.

BTSG carries a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. 

Phibro, currently carrying a Zacks Rank #1, has an estimated long-term earnings growth rate of 12.8% compared with the industry’s 13.3%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 20.8%. PAHC’s shares have rallied 18.9% against the industry’s 15.4% decline in the past year.

Cardinal Health, currently carrying a Zacks Rank #2, has an earnings yield of 4.9% compared with the industry’s 5.9%. Shares of the company have surged 76.5% compared with the industry’s 3.4% growth. CAH’s earnings beat estimates in each of the trailing four quarters, with the average surprise being 9.4%.

ToplineNetflix on Friday announced it had reached a deal to acquire Warner Bros.— including the company’s film and television studios and streamer HBO Max—for $82.7 billion, in move that follows a weeks-long bidding war in which the streaming giant beat out Paramount and Comcast.

Warner Bros. Discovery has reportedly entered exclusive talks with Netflix for a sale of its studio and TV businesses.

Anadolu via Getty Images

Key FactsIn a press statement the company said the cash and stock deal is valued at $27.75 per Warner Bros. Discovery share and it will close after the media giant’s TV network business is spun off into a separate public company, Discovery Global.

The deal is subject to regulatory approvals and is expected to be completed in the third quarter of 2026.

If it goes through, each WBD shareholder will receive $23.25 in cash per share and $4.501 worth of shares of Netflix’s stock.

According to Deadline and CNN, Paramount Skydance had offered $27 per share for the entire Warner Bros. Discovery business, including its cable channels like CNN and TNT.

Comcast also made a bid only for Warner Bros. Discovery’s studio and streaming businesses.

Bloomberg previously reported that Netflix is offering Warner Bros. Discovery a $5 billion breakup fee if regulators don’t clear the deal.

How Has The Market Reacted To Netflix And Wbd’s Talks?Warner Bros. Discovery’s shares rose 1.22% to $24.84 in premarket trading early on Friday. Netflix shares on the other hand fell 2.33% to $100.81 in early trading, after sliding 0.71% on Thursday.

What Did Netflix Say About Theatrical Releases And Hbo Max?In the statement announcing the merger, Netflix said it “expects to maintain Warner Bros.’ current operations...including theatrical releases for films.” The streaming giant, however, didn’t mention how long the theatrical window will be for Warner’s films after the acquisition. The statement also said: “By adding the deep film and TV libraries and HBO and HBO Max programming, Netflix members will have even more high-quality titles from which to choose.” It is unclear if this means HBO’s library will be folded in to Netflix or if it will remain a separate streaming service.

What Do We Know About Paramount’s Bid?Bloomberg and Variety reported that Paramount Skydance has cried foul over the sales process, labeling it “tainted.” In a letter sent to Warner’s CEO David Zaslav, Paramount’s attorneys alleged that Warner’s board had “embarked on a myopic process with a predetermined outcome that favors a single bidder,” refering to Netflix. The December 3 letter added that Warner appeared to have “abandoned the semblance and reality of a fair transaction process, thereby abdicating its duties to stockholders.” In an earlier letter sent on December 1, Paramount had argued that the Netflix deal would never get regulatory approval. “The simple truth is that a deal with Netflix as the buyer likely will never close…Netflix is the only remaining Big Tech company that has not faced serious global antitrust enforcement, but attempting to acquire the WBD assets will change that.”

What To Watch ForEarlier this week, the New York Post reported that senior White House officials had flagged antitrust concerns over Netflix’s bid to acquire Warner. The report said White House officials also suggested in a meeting that Netflix’s market power merited a broader investigation into its dominance. In a separate report on Thursday night, the New York Post reported that Paramount Skydance CEO David Ellison met with Trump officials and key lawmakers in Washington, D.C. this week to make his case against Netflix’s potential acquisition of Warner. Ellison was reportedly joined by his company’s legal team, which is led by Makan Delrahim, who served as the Justice Department’s anti-trust chief during Trump’s first term. The Paramount chief’s father Larry Ellison is the second wealthiest person in the world and has built close ties with the Trump White House.

Key BackgroundIn June, Warner Bros Discovery announced plans to split into two publicly traded firms, the first of which would be a “Streaming & Studios” company that would include “Warner Bros. Television, Warner Bros. Motion Picture Group, DC Studios, HBO, and HBO Max.” The other would be a “Global Networks” spin-off comprising the company’s television networks, including “CNN and TNT Sports” in the U.S. However, after completing its acquisition of Paramount, the Ellison-led Skydance (now Paramount Skydance) made an unsolicited offer to acquire Warner’s entire business at $20 per share. The HBO-owner rejected the offer deeming it to be too low, but soon announced it was open to a sale and had received interest from “multiple parties.”

Further ReadingWarner Bros. Begins Exclusive Deal Talks With Netflix (Bloomberg)

The New York Times sues startup Perplexity for copyright infringement, expanding its legal fight against generative-AI companies that it says steal and then profit from its content.

HomeEarnings AnalysisTech 

SummaryMethode Electronics (MEI) remains a hold as transformation progress is not yet reflected in profitability, with automotive losses offsetting industrial gains.
Q2 results highlight deepening automotive segment losses and weakening revenue, while industrial margins and cash flow discipline provide some stability.
Management maintains ambitious FY2026 guidance, but recovery is still speculative; cash flow improvement and plant initiatives offer cautious optimism.
High net debt, dividend cuts, and ongoing operational risks underscore the need for further evidence before increasing exposure to MEI.
Eoneren/E+ via Getty Images

Since my last article about Methode Electronics (MEI), I have been following it in hopes to open a position if the situation improves. In that time the company’s strategic direction did not change much, MEI

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You

LOS ANGELES--(BUSINESS WIRE)--GKIDS, the producer and distributor of artist-driven and award-winning animation from around the world, and IMAX Corporation (NYSE: IMAX), an innovator in entertainment technology, announce an expanded partnership to bring further 4K Studio Ghibli restorations to North American theaters in 2026 and beyond. The announcement comes after the highly successful IMAX release of “Princess Mononoke,” which is the second-highest grossing vault release ever for IMAX. The nex.

ATLANTA--(BUSINESS WIRE)--Corpay, Inc., (NYSE: CPAY), the corporate payments company, today announced that the Company will be attending the Raymond James TMT and Consumer Conference on Tuesday, December 9, 2025 in New York, NY. Management will participate in a fireside chat beginning at 8:40 AM ET. Investors and interested parties can access this presentation by visiting the Company's investor relations website at https://investor.corpay.com/. About Corpay Corpay, Inc. (NYSE: CPAY) is a global.

December 05, 2025 08:30 ET

 | Source:

CG Oncology Inc.

Cretostimogene demonstrated HG-EFS at 3- 6- and 9-months of 95.7%, 84.6% and 80.4%, respectively, in HR BCG UR Ta/T1 Disease in BOND-003 Cohort PCORE-008 Cohort A Data in HR BCG-Naïve NMIBC demonstrates 88% CR and favorable safety with optimized administration Robust clinical pipeline that spans multiple late-stage studies across intermediate- and high-risk NMIBC IRVINE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced topline data from BOND-003 Cohort P and first results from CORE-008 Cohort A which demonstrated promising efficacy, safety and tolerability. These data will be presented today as Late-Breaking Abstracts at the Society of Urologic Oncology (SUO) 26th Annual Meeting. 

“For people living with bladder cancer, the need for primary treatment of newly diagnosed NMIBC and a durable, bladder-sparing option for those with BCG unresponsive disease is urgent. New data from BOND-003 Cohort P and CORE-008 Cohort A add to a growing body of evidence demonstrating cretostimogene’s potential to become a backbone treatment across the NMIBC spectrum, if approved. The topline efficacy, safety, and tolerability announced today are consistent with what we previously observed with the pivotal Phase 3 monotherapy data, but in an even more prevalent NMIBC population, notably BCG-UR papillary-only,” said Trinity J. Bivalacqua, M.D., Ph.D., Urologic Oncologist at University of Pennsylvania.

“We are delighted to share new and more mature data in different sub-groups, underscoring our commitment to address the broadest range of NMIBC patients. This sets us up for the future expansion and long-term success of cretostimogene. With its best-in-disease profile and dual MOA, we are confident that cretostimogene will continue to demonstrate differentiated data from current and investigational NMIBC therapies,” said Ambaw Bellete, President & Chief Operating Officer at CG Oncology.

TOPLINE BOND-003 COHORT P RESULTS
Results from the BOND-003 Cohort P clinical trial of cretostimogene monotherapy in patients with BCG-UR papillary-only NMIBC demonstrate encouraging HG-EFS and a consistent, well-tolerated safety profile. The study’s primary endpoint is High-Grade Event-Free Survival (HG-EFS). As of the September 1, 2025, data cut-off, in 51 efficacy evaluable patients, Kaplan-Meier estimates of HG-EFS at 3- 6- and 9-months are 95.7% (95% CI 83.8 – 98.9), 84.6% (95% CI 68.6 – 92.9%) and 80.4% (95% CI 62.3-90.4%), respectively.

A favorable safety and tolerability profile was observed with no Grade 3 or greater treatment-related adverse events (TRAEs) and no deaths reported. To date, no patients have undergone a radical cystectomy or progressed to MIBC. No treatment-related discontinuation of cretostimogene was observed. There were no missed doses, or dose delays due to TRAE. The most common TRAEs (≥10%) were bladder spasms, dysuria, pollakiuria, and hematuria.

The study has completed enrollment with 56 patients receiving cretostimogene across 35 clinical sites in the United States and Japan.

CORE-008 Cohort A Results
The first results from CORE-008 Cohort A demonstrate that cretostimogene monotherapy has promising clinical efficacy, tolerability, and safety in patients with high-risk, BCG-naïve NMIBC with CIS, compared with outcomes observed in historical BCG-naive trials. The primary endpoint is Complete Response (CR) at any time. As of the September 1, 2025, data cut off, the overall CR rate at any time in evaluable patients is 83.7% (41/49) (95% CI 70.3-92.7%) with the original administration achieving a 79.2% CR rate (57.8, 92.9) in 19 out of 24 patients as compared with the optimized administration which resulted in an 88.0% CR rate (68.8, 97.5) in 22 out of 25 patients.

The safety and tolerability profile is consistent with prior clinical trials of cretostimogene. The most common adverse events are low grade and localized to the bladder. There are no related serious adverse events (SAEs), Grade 3+ adverse events or treatment-related discontinuations. No patients progressed to MIBC or metastatic disease.

CORE-008 Cohort ACR Rate,
% (95% CI)Safety
(n=54)  Any GradeGrade ≥ 3Original Administration (five-step)79.2% (57.8, 92.9)116 (59.3%)10 (0%)Optimized Administration (two-step)88.0% (68.8, 97.5)213 (48.1%)0 (0%)Overall83.7%29 (53.7%)0 (0%) 1 CR rate in 19 out of 24 patients; safety in 27 patients
2 CR rate in 22 out of 25 patients; safety in 27 patients

About Cretostimogene Grenadenorepvec
Cretostimogene is an investigational, intravesically delivered oncolytic immunotherapy that has been studied in a clinical development program, which includes more than 400 patients with Non-Muscle Invasive Bladder Cancer (NMIBC). This program includes two Phase 3 clinical trials: BOND-003 for high-risk BCG-unresponsive NMIBC and PIVOT-006 for intermediate-risk NMIBC. CG Oncology also has a Phase 2 trial, CORE-008, evaluating the safety and efficacy of cretostimogene in high-risk NMIBC. Additionally, we have initiated an Expanded Access Program for cretostimogene in North America for patients who are unresponsive to BCG and meet certain program eligibility requirements. Cretostimogene is an investigational candidate, and its safety and efficacy have not been established by the FDA or any other health authority.

About CG Oncology
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.

Forward-Looking Statements
CG Oncology cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. The forward-looking statements are based on our current beliefs and expectations and include, but are not limited to, the potential therapeutic benefits of cretostimogene for high-risk and intermediate-risk NMIBC patients, cretostimogene’s potential as a backbone immunotherapy across the NMIBC spectrum, and that cretostimogene results support optimized administration from a five-step process to a two-step process. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in our business, including, without limitation: interim results of a clinical trial are not necessarily indicative of final results and one or more of the clinical outcomes may materially change as patient enrollment continues, following more comprehensive reviews of the data, and as more patient data becomes available; potential delays in the commencement, enrollment and completion of clinical trials, including the BOND-003 and PIVOT-006 trials; we may use our capital resources sooner than expected and they may be insufficient to allow us to achieve our anticipated milestones; our dependence on third parties in connection with manufacturing, shipping and clinical and preclinical testing; results from earlier clinical trials and preclinical studies not necessarily being predictive of future results; unexpected adverse side effects or inadequate efficacy of cretostimogene that may limit its development, regulatory approval, and/or commercialization; and other risks described in our filings with the Securities and Exchange Commission (SEC), including under the heading “Risk Factors” in our annual report on Form 10-K and other filings that we make with the SEC from time to time (which are available at http://www.sec.gov). You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contacts:
Media
Sarah Connors
Vice President, Communications and Patient Advocacy, CG Oncology
[email protected]

Investor Relations
Megan Knight
Vice President, Investor Relations, CG Oncology
[email protected]

In brief
Ethereum's 90-day options skew sits at -2.8%, notably less bearish than Bitcoin's -4%, indicating traders see less downside risk for the former.
Analysts link Ethereum’s relative strength to the recent Fusaka upgrade, major treasury purchases, and a more favorable macro backdrop for rate cuts.
Despite the improved skew, experts caution that the market is far from the bullish extremes of early Q4 and lacks sustained ETF inflows for a major rally.
Ethereum traders are positioning with more optimism than their Bitcoin counterparts, options data shows.

Despite a broadly cautious investor stance, the divergence suggests that traders see less immediate downside risk for the second-largest crypto by market cap than for Bitcoin.

That outlook aligns with recent spot price performance.

Ethereum is trading just above $3,100, down around 2% over the past 24 hours, according to CoinGecko data. Its year-to-date performance of -3% is slightly better than Bitcoin's -6%, though both assets have declined by double-digits since October, with Ethereum down 19% and Bitcoin down 25%.

For longer-dated options, Ethereum's 90-day skew sits at -1.7%, which is "noticeably more bullish" than Bitcoin's -4%, Sean Dawson, head of research at on-chain options platform Derive, told Decrypt. "In other words, traders are more eager to buy insurance for Bitcoin than for Ethereum."

The negative skew for both assets shows a continued greater appetite for protective put options than for bullish calls. However, the depth of that bearishness is where they diverge.

Despite a recent recovery fueled by dovish Federal Reserve sentiment, the market is "very far from the bullish sentiment we saw at the start of Q4," Dawson said. He advises caution in the weeks ahead.

Ethereum bears retreatSignals point to a tentative thaw in bearishness for Ethereum specifically.

"We are seeing signs of reduced bearishness in Ethereum options markets, though derivatives traders are still falling short of pricing in a complete 'Santa rally'," Thahbib Rahman, research analyst at crypto research platform Block Scholes, told Decrypt.

The put-call skew for short-dated Ethereum contracts briefly turned positive recently, marking the most bullish positioning since late October, Rahman highlighted. Furthermore, the firm's proprietary BlockScholes Risk-Appetite Index for Ethereum appears to be bottoming, a pattern that has historically preceded sentiment turnarounds.

Rahman drew parallels to the market structure in May 2025, which preceded a significant rally.

"Back then, the rally began on the back of a more positive macro environment, the Pectra upgrade was launched, and in the following weeks, Ethereum spot ETFs had their best run of inflows," Rahman said.

Similar catalysts are in play now, he noted: markets are pricing in a potential December Fed rate cut, Ethereum's Fusaka upgrade went live to improve layer-2 efficiency, and entities like BitMine have made major ETH purchases. The missing component, he said, is a sustained wave of inflows into spot Ethereum ETFs, which would be needed to fuel a more decisive bullish move.

The technical positioning, noted in options market data, underscores a market that, while not expecting a major rally, is cautiously downgrading the probability of an Ethereum-specific downturn.

The perspective from retail prediction markets, however, contrasts with the cautious skew in professional options. Users on Myriad, owned by Decrypt’s parent company, Dastan, give Bitcoin a 75% chance of reaching $100,000 before $69,000, a notably more bullish outlook than the 49% chance they assign Ethereum hitting $4,000 before $2,500.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

What to Know:

Solana stalls near $140 and ETF flows reshape liquidity as DEX volumes cool off.
Money starts to rotate into projects with real narratives or structural links to Bitcoin’s liquidity base.
Bitcoin Hyper brings SVM-powered smart contracts and ultra-fast execution to Bitcoin, aiming to unlock DeFi and dApps for BTC holders.
Maxi Doge channels trader culture into a meme token with competitions, dynamic staking, and a growing presale-backed war chest.

Solana’s the talk of the town.

$SOL has been grinding against the $140 ceiling as spot altcoin ETFs soak up liquidity and DEX volumes cool off. Perps funding has normalized, leverage is bleeding out, and the easy ‘buy-any-SOL-ecosystem-name’ trade looks tired for now.

When that happens, the hot money usually rotates. You start to see flows move away from the obvious beta plays and into projects with real narratives, cleaner tokenomics, or structural links to Bitcoin’s liquidity base. In 2021, it was EVM sidechains. In 2024, it was Solana DeFi. This post-SOL catch-up phase feels different.

Regulated ETFs pulling in capital make it harder for pure meme beta to sustain parabolic runs without substance. Traders are suddenly asking annoying questions again: what does this chain actually do; what’s the throughput, where does yield come from; why does this token need to exist?

That backdrop is exactly where three very different plays stand out as the next crypto to explode:

1. Bitcoin Hyper ($HYPER) as a high-throughput Bitcoin Layer 2.

2. Maxi Doge ($MAXI) as a leverage-obsessed meme.

3. Dogwifhat ($WIF) as Solana’s culture coin that already proved it can run when conditions align.

1. Bitcoin Hyper ($HYPER): SVM Powered Bitcoin Layer 2
Bitcoin Hyper ($HYPER) is bridging the gap between Bitcoin’s security and Solana’s speed. By using Solana Virtual Machine technology to run a Layer 2 on top of Bitcoin. It delivers the holy grail of crypto: sub-second transaction times and penny fees, all secured by the Bitcoin network.

Why it matters:

$BTC Deployed: It turns ‘store of value’ Bitcoin into programmable money for DeFi, NFTs, and Gaming.
Dev-Ready: Uses familiar Rust-based tools, inviting the vast Solana developer community to build on Bitcoin.

We break down the project in more detail in our ‘What is Bitcoin Hyper’ guide, but this magic stems from the use of a canonical bridge to ensure your wrapped $BTC is transferred safely between layers.

The market is taking notice. The presale has already smashed past $29M. Even more telling? On-chain sleuths have spotted heavy whale activity, with one buy hitting $500K. Liquidity is loading up, and smart money is getting in early.

Our experts see $HYPER potentially hitting $0.08625 by the end of 2026, which could mean an ROI of 544% if you invested at today’s price. And with 40% staking rewards for those in get in early, there are even more ways to potentially see a return.

2. Maxi Doge ($MAXI): Meme Play for the 1000x Leverage Mindset
Maxi Doge ($MAXI) is built around one idea: never skip leg day, never skip a pump. The project leans hard into a ‘240-lb canine juggernaut’ persona, channeling the 1000x leverage mentality that still defines a big slice of crypto trading culture.

Maxi Doge’s future could be gamified speculation. Holder-only trading competitions, leaderboards, and rewards will create a meta-game where traders flex their PnL and grind for status.

The ‘Leverage King Culture’ branding turns what many people already do, degenerate trading, into a community sport instead of an isolated experience on a sterile exchange screen. Want in? We’ve got you covered, ‘bro’, with our ‘How to Buy Maxi Doge’ guide.

Under the hood, the Maxi Fund treasury is designed to support liquidity and partnerships, giving the team ammunition for CEX listings, marketing pushes, and cross-ecosystem collabs if momentum builds. That matters in a meme cycle where visibility and depth can make or break a token once the initial hype fades.

The Maxi Doge presale has raised over $4.2M with tokens currently available at $0.0002715, putting it firmly in micro-cap territory where even modest inflows can move the needle. Staking offers a dynamic APY currently at 72%, rewarding early believers willing to lock in and help stabilize the base.

If you want meme exposure aligned with trader culture rather than pure randomness, check out the $MAXI presale.

3. Dogwifhat ($WIF): Solana’s Culture Coin With Robinhood Reach
Dogwifhat ($WIF) is already a proven name in the Solana meme sector, less about utility and more about culture, branding, and community. It’s a meme coin that doesn’t pretend to solve DeFi fragmentation or reinvent infrastructure; it leans fully into being a digital totem for Solana’s fun side.

It couldn’t be simpler. It’s a dog… ’wif’ a hat.

Built on Solana, $WIF benefits from high-speed, low-fee transactions, making it easy for retail traders to rotate in and out without worrying about gas overhead on smaller tickets. That’s critical in meme rotations, where traders often ladder in with many small buys and social sentiment moves fast.

The project’s ecosystem is driven heavily by its community, with fun tools like ‘WIF Hat Generators’ helping push the brand into every corner of Crypto Twitter and beyond. Significant whale and retail interest have translated into deep liquidity and high trading volumes during peak cycles, proving that culture plus liquidity is still a powerful combination.

A major inflection point came in May 2025, when Robinhood listed $WIF, triggering a sharp price spike and cementing it among the leading Solana meme coins. Today, $WIF is frequently cited as a top contender for traders who still want Solana exposure but prefer pure meme beta over infrastructure narratives.

Recap: With Solana pinned near $140 and altcoin ETFs soaking up attention, traders are rotating into clearer narratives. Bitcoin Hyper, Maxi Doge, and Dogwifhat each target different slices of that demand.

Remember, this isn’t intended as financial advice, and you should always do your own research before investing.

Authored by Aaron Walker , NewsBTC — https://www.newsbtc.com/news/next-crypto-to-explode-as-sol-hits-140-ceiling

TLDR:

Table of Contents

TLDR:XRP ETF Inflows Approach MilestoneLiquidity and Volume Diverge From Market ConditionsGet 3 Free Stock Ebooks

XRP ETF sees 14 consecutive days of inflows, with zero outflows recorded so far.
Fund nears $1 billion milestone, marking fastest start among recent crypto ETFs.
XRP trading volume rises 7%, while BTC and ETH volumes drop 16% and 9% respectively.
Liquidity pool forms above $2.18, signaling potential areas for price movement.

The US Spot XRP ETF has pushed toward the $1 billion mark after a 14-day inflow streak. 

The steady capital movement is emerging during a period when most major crypto assets are recording reduced activity, giving XRP a rare position of strength. Market participants are closely watching this trend as the ETF’s consistent inflows contrast with declining volume across the broader landscape.

XRP’s momentum aligns with shifting liquidity conditions in the short term, especially as new data points continue to surface. 

The asset is standing out not only through ETF demand but also through trading behavior that diverges from the market slowdown. With ETF inflows persisting and trading volume rising, XRP is shaping a narrative that differs from other large-cap cryptocurrencies.

XRP ETF Inflows Approach Milestone
US Spot XRP ETF nears $1B as 14-Day inflow streak continues, creating one of the strongest early performances among recent crypto fund launches. 

Rand noted that the ETF has seen 14 straight sessions of inflows with zero outflows, reflecting stable investor interest. This uninterrupted activity is offering a clearer picture of market appetite for regulated XRP exposure.

The approaching $1 billion mark demonstrates how capital is moving into the ETF even as broader market volumes decline. 

Investors appear to be responding to the asset’s relative strength during a quieter phase for the industry. As inflows accumulate, traders are monitoring how this demand influences short-term liquidity and price behavior.

These inflows are becoming a key focus for institutional desks evaluating emerging patterns across crypto ETFs. 

Compared to previous launches, the pace indicates a solid start that continues to attract attention. The streak also signals that market participants are positioning despite wider consolidation.

Liquidity and Volume Diverge From Market Conditions
Additional momentum is coming from short-term liquidity patterns forming above the $2.18 zone. 

STEPH IS CRYPTO reported that the heatmap is building a large liquidity pool in that region, suggesting an area that could draw price movement. This development adds another component to how traders interpret current XRP positioning.

At the same time, reports pointed out that XRP was the only major asset posting increased trading volume in the past 24 hours. 

Bitcoin’s volume fell 16 percent and Ethereum’s declined 9 percent, with most altcoins showing similar drops. XRP, however, recorded a 7 percent rise, setting it apart from the market-wide decrease.

The contrasting volume trend supports the ongoing ETF inflows, as higher activity often aligns with stronger market engagement. 

With other assets cooling, XRP continues to capture attention from traders monitoring liquidity zones and evaluating short-term developments. This pattern is shaping a clearer narrative around the asset’s current performance.

JPMorgan sets Bitcoin's fair value at $170,000 but warns that the near-term direction hinges on the Strategy's financial position and the upcoming MSCI index decision.

Newton Gitonga2 min read

5 December 2025, 12:58 PM

JPMorgan has identified a critical factor influencing Bitcoin's near-term price movement. The investment bank points to Strategy, the world's largest corporate Bitcoin holder, as a key variable in the cryptocurrency's trajectory. Strategy's financial health and market positioning could determine whether Bitcoin maintains momentum or faces renewed pressure in the coming months.

Enterprise Value Ratio Emerges as Critical MetricThe company's Enterprise Value to Bitcoin ratio stands at 1.13, a figure JPMorgan considers essential for stability. This metric must remain above 1 to avoid forced selling scenarios. Strategy holds $1.44 billion in cash reserves, providing a two-year buffer for operational obligations. The financial cushion offers protection against market volatility and operational pressures.

Bitcoin's price dynamics have become increasingly intertwined with corporate balance sheet strategies. This represents a shift from previous market cycles, which were driven primarily by retail sentiment and macroeconomic factors. Institutional Bitcoin holdings now play a measurable role in price formation and market liquidity.

MSCI will announce its decision on the Strategy's index inclusion status on January 15. The outcome carries implications for Bitcoin's short-term direction. Continued inclusion would maintain institutional investment flows and support potential price recovery. Exclusion would create headwinds, though JPMorgan suggests much of this risk has already been reflected in current valuations.

Index decisions affect passive fund allocations and institutional exposure limits. Strategy's presence in major indices channels capital into Bitcoin indirectly through equity holdings. The company's stock performance and Bitcoin's price movements have shown correlation patterns throughout 2024.

Long-Term Valuation Target Set at $170,000JPMorgan's analysis extends beyond immediate catalysts. The bank estimates Bitcoin's fair value to be near $170,000 over the medium term. This valuation reflects anticipated adoption trends and improved market liquidity conditions. The projection assumes continued institutional participation and favorable regulatory developments.

Corporate Bitcoin accumulation strategies have introduced new market dynamics. Balance sheet exposure creates feedback loops between equity markets and cryptocurrency valuations. Strategy's position as the dominant corporate holder amplifies this effect.

The bank's framework highlights how Bitcoin has evolved from a speculative asset to one influenced by corporate finance decisions. Traditional financial metrics now matter for cryptocurrency price analysis. Strategy's operational performance, debt management, and capital allocation choices have a ripple effect on Bitcoin markets.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Newton Gitonga

Newton Gitonga covers cryptocurrencies, blockchain, and digital finance. He specializes in breaking down complex trends with clear, data-driven reporting. His work focuses on market analysis, technical insights, and the evolving role of altcoins in shaping global markets.

Read more about

Bitcoin

Trading volumes also dropped sharply thanks to weaker risk appetite as Bitcoin hovered near $91,000. Analysts believe that despite short-term selling, long-term fundamentals are still constructive, with exchange balances now at their lowest levels since 2017. At the same time, concerns are emerging about Bitcoin’s ability to replicate its strong start to 2025 in January of 2026. 21Shares’ Ophelia Snyder warned that fragile sentiment and macro uncertainty could limit upside. 

Bitcoin ETFs See Sharp OutflowsUS spot Bitcoin ETFs saw a sharp reversal in flows on Thursday after recording $194.6 million in net outflows. This was the largest daily pullback in two weeks as volatility continued to unsettle traders. 

Data from Farside Investors shows BlackRock’s IBIT leading the decline with $112.9 million in outflows, followed by Fidelity’s FBTC at $54.2 million. Other major issuers, including VanEck’s HODL, Grayscale’s GBTC, and Bitwise’s BITB, also logged redemptions. The downturn came just one day after a smaller $14.9 million net outflow and is the biggest single-day withdrawal since Nov. 20.

Bitcoin ETF flows (Source: Farside Investors)

The pickup in outflows coincided with a drop in trading activity across the ETF suite. Total spot Bitcoin ETF volume fell to $3.1 billion on Thursday, down from $4.2 billion on Wednesday and $5.3 billion on Tuesday. This could be a sign that there is reduced risk appetite as Bitcoin’s price action is still quite choppy. Bitcoin slipped 2.4% over the past 24 hours to $91,227 after briefly plunging to the $84,000 range earlier in the week.

BTC’s price action over the past week (Source: CoinMarketCap)

Market analysts say the ETF weakness is being driven less by retail sentiment and more by the unwinding of sophisticated basis trades. According to Nick Ruck, director at LVRG Research, the recent compression of the futures-spot spread below breakeven forced arbitrage desks to exit positions, triggering selling pressure across both ETFs and underlying BTC holdings at a time of elevated volatility. Ruck added that traders are now laser-focused on upcoming US inflation reports and the Federal Reserve’s Dec. 10 meeting, where expectations of a 25-basis-point rate cut could help restore confidence if it signals a broader easing cycle.

Despite the outflows, some analysts argue that Bitcoin’s structural backdrop is still strong. Timothy Misir, head of research at BRN, said that exchange balances fell to around 1.8 million BTC, the lowest since 2017. He said the market “opened with quiet strength,” due to persistent accumulation, thinner exchange supply, and price stability above the True Market Mean. What the market needs now, he added, is a decisive breakout into the $96,000 to $106,000 range to reignite bullish momentum.

The cautious sentiment wasn’t limited to Bitcoin. Spot Ethereum ETFs also saw $41.6 million in net outflows on Thursday, reversing the $140.2 million in inflows that was recorded the previous day. 

Bitcoin’s 2026 Outlook CloudsBitcoin may also struggle to repeat its strong early-2025 price gains as the market heads into 2026. This is  according to 21Shares co-founder Ophelia Snyder. 

In a recent interview, Snyder said the factors driving current volatility are unlikely to resolve quickly, making a similar January rally far from guaranteed. She pointed out that Bitcoin ETFs often see renewed inflows at the start of the year as investors rebalance portfolios, but added that this dynamic depends heavily on sentiment — something the market is currently lacking.

Ophelia Snyder

Bitcoin’s momentum shifted sharply after reaching a peak of $109,000 on Jan. 9, 2025, one day before Donald Trump’s inauguration. The asset climbed even more to an all-time high of $125,100 on Oct. 5, but the rally reversed after a massive $19 billion liquidation event on Oct. 10. That shock triggered a much more cautious outlook among traders who previously expected a stronger finish to the year. 

Despite the near-term uncertainty, Snyder said that she is more optimistic about the long-term trajectory. She sees the current correction as a reaction to risk-off sentiment across financial markets rather than a crypto-specific issue, and suggested Bitcoin’s underlying fundamentals are still intact. She also pointed to several potential upside catalysts, including the expansion of crypto ETFs across major investment platforms, increased interest from governments exploring digital assets, and rising demand for alternative stores of value beyond gold.

Still, Snyder warned that macro conditions could also drive Bitcoin lower. Persistent risk-off behavior in global markets or continued strength in gold could weigh on demand from traditional investors. Not everyone shares the tempered outlook. BitMine chair Tom Lee recently reiterated his view that Bitcoin will hit a new all-time high before the end of January 2026. 

Bitcoin monthly returns (Source: CoinGlass)

Historically, the month has been favorable for the asset. In fact, since 2013, Bitcoin averaged a 3.81% return in January, according to data from CoinGlass.

JPMorgan Retains Gold-Linked $170K Bitcoin Target Despite Recent PlungeThe bank’s volatility-adjusted bitcoin-to-gold model still points to a theoretical price around $170K over the next six to twelve months. Dec 5, 2025, 1:03 p.m.

Despite bitcoin's recent sharp price declines, Wall Street Bank JPMorgan is sticking to its volatility-adjusted BTC-versus-gold model target which points to a theoretical price near $170,000 over the next six to 12 months.

The world's largest cryptocurrency was trading around $91,200 at publication time.

STORY CONTINUES BELOW

Strategy (MSTR) is a key driver for bitcoin BTC$90,860.13, with markets watching its enterprise value-to-bitcoin holdings (mNAV) ratio, now about 1.13, as a key read on forced-selling risk if it slips below 1.0, analysts led by Nikolaos Panigirtzoglou wrote in the Wednesday report.

It’s encouraging that the company’s mNAV is still holding above 1.0, the report said.

The analysts pointed to the company's $1.4 billion reserve fund as a buffer against needing to sell bitcoin, and flagged MSCI’s Jan. 15 index decision as an asymmetric catalyst: exclusion is largely priced in after the stock’s steep fall since Oct. 10, while a positive outcome could fuel a sharp rebound.

The company founded by Michael Saylor is the largest corporate holder of bitcoin, with 650,000 BTC on its balance sheet. The firm has been under fire in recent weeks after the price of the leading cryptocurrency plummeted from an all-time high over $120,000 to as low as $82,000.

Among other reasons, the bank linked bitcoin's recent pullback to renewed pressure on mining in China and a retreat by higher-cost miners elsewhere, some of whom have reportedly sold bitcoin as energy costs stay high.

JPMorgan reduced its bitcoin production-cost estimate to $90,000 from $94,000 after recent drops in the hashrate and mining difficulty.

The hashrate is the network’s total computing power devoted to mining and validating transactions on a proof-of-work blockchain, and it’s often used as a proxy for mining competition and difficulty.

A prolonged stretch below production cost can become self-reinforcing as marginal miners exit, reducing difficulty and pushing the cost estimate lower, as seen in 2018, the analysts said.

The post-Oct. 10 deleveraging in perpetual futures appears mostly behind, the report added.

Read more: JPMorgan Warns MSCI Decision Could Force Strategy Out of Top Equity Indices

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Protocol Research: GoPlus Security

Nov 14, 2025

What to know:

As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.View Full Report

More For You

Crypto Markets Today: Bitcoin Slides to $91K as ETF Outflows Deepen Market Anxiety

1 hour ago

Bitcoin’s early week rally unraveled as sharp ETF outflows, aggressive derivatives deleveraging and muted altcoin reactions to catalysts pulled the broader crypto market lower.

What to know:

Bitcoin fell to $91,200 as BlackRock’s IBIT notched another $113 million in outflows, pressuring sentiment while equities were little changed.Futures open interest slid to $21 billion, basis and funding remained muted, and options positioning stays bullish with call-side skew rising.Ether erased post-Fusaka gains, while the CD20 and memecoins weakened further.ZEC y TRX desafiaron la tendencia con una fuerza destacada.Read full story

In an industry that thrives on noise and chaos, Cardano is betting its future on a “quiet” hard fork and improved coordination among its leading internal stakeholders. The blockchain network is preparing to execute a technical upgrade engineered to be virtually invisible to the market.

Bitcoin (BTC) and Ethereum (ETH) traded slightly lower on Friday, but as a new report by Bybit and Block Scholes points out, the top coins are holding onto recent gains amid signals of a market recovery.

Many other altcoins have also maintained the upward structure after Monday’s crash, with momentum likely to be anticipated if tailwinds materialize.

BTC, the bellwether of the industry, has its price currently at $91,232, while ETH trades at $3,124.

Crypto market shows early signs of recovery: Bybit & Block Scholes report
Copy link to section

A newly released joint report from leading cryptocurrency exchange Bybit and analytics firm Block Scholes outlines the fragile yet promising rebound in market sentiment.

The analysis draws on proprietary data from Bybit’s trading platform and Block Scholes’ advanced sentiment modeling to paint a picture of cautious resurgence.

The report notes that retail investor participation has rebounded, with spot trading volumes for BTC and ETH pairs increasing. Glassnode says most losses have been for recent buyers.

$BTC‘s drawdown has triggered the largest spike in realized losses since the FTX collapse in late 2022.
STHs account for the bulk of the losses, while LTH losses stay comparatively contained, indicating that the stress is largely on recent buyers.
📉glassno.de/4iBirIe

Block Scholes’ sentiment algorithm, which aggregates social media buzz, Google Trends, and exchange inflows, detected a 10% reduction in negative keyword associations tied to “crypto crash” and “regulation fears.”

“While the market remains sensitive to external shocks, these metrics suggest a bottoming process is underway,” stated Dr. Elena Vasquez, lead analyst at Block Scholes.

As such, analysts are cautioning against over-optimism.

This is down to the fact that the macro picture is very much in play. Per the report, sustained recovery across risk assets hinges on factors such as the Federal Reserve rate cut and policy communications. The regulatory landscape is also crucial.

Nonetheless, it forecasts a potential 10-15% appreciation in BTC by year-end if sentiment holds above 35 on the Fear & Greed scale.

Bitcoin, Ethereum at key levels
Copy link to section

BTC and ETH are both looking to consolidate their gains after recent bloodbaths.

Currently, both assets are testing pivotal technical thresholds. Movement in either direction will significantly dictate the trajectory of the broader crypto market.

Bitcoin’s current perch near $91k aligns with its 50-day exponential moving average (EMA).

The price level has historically acted as dynamic support. Ethereum, meanwhile, hovers above $3,100. Bulls are flirting with the upper boundary of a multi-month ascending triangle pattern.

Analysts see a bounce to above $100k and $3,500 as key to the immediate sentiment. Dips could be catastrophic to short-term targets.

“Most Bitcoin on-chain indicators are bearish. Without macro liquidity, we enter a bear cycle,” Ki Young Ju, chief executive officer of CryptoQuant, said.

Ju shared the sentiment via X, with this coming as Bitcoin struggled below $90k and ETH below $3k. Recovery above the levels gives bulls a slight advantage. However, weakness dominates, and bears could yet pounce.

Bitcoin’s price has entered one of its tightest trading ranges in weeks, creating a pressure zone where volatility is building beneath the surface. Market depth is thinning, leverage has reset, and liquidity pockets on both sides are stacked—conditions that historically precede sharp directional moves. As institutional flows remain stable and long-term holders quietly accumulate, traders now find themselves navigating a high-tension setup. 

Whether Bitcoin breaks upward or slips into a deeper correction will depend on how the price reacts to the narrow band of resistance overhead and the liquidity traps forming just below support. The next move won’t be gradual—it will be decisive.

Market Cools Ahead of Bitcoin’s Next Major MoveBitcoin’s latest drop didn’t emerge from nowhere—it was a direct collision with one of the largest high-leverage long clusters on the liquidation map. The chart shows a dense pocket of traders using aggressive leverage, many positioned with liquidation levels stacked tightly together. When price dipped into this zone, it triggered a chain reaction: forced liquidations, cascading sell orders, and rapid downward velocity.

These events are mechanical, not emotional. Market makers, algos, and large players often target liquidity pools where liquidations are guaranteed, allowing them to fill large orders with minimal slippage. This is why the decline appeared “surgical”—it followed the liquidity, not a trendline or indicator.

With most high-leverage longs now flushed out, open interest has reset and funding has normalized, creating a cleaner base for the next directional move. This reset is crucial ahead of any Bitcoin price analysis, as it determines whether the market is ready for a rebound or further downside.

Bitcoin Price Analysis: A Breakout or Another Trap?Bitcoin is now resting just above a crucial structural zone, where both bulls and bears have repeatedly clashed this month. The price action shows a clear contraction in volatility, with BTC forming a tightening range that often precedes explosive movement. Market depth has stabilized, yet liquidity pockets remain thin on both sides—meaning any strong impulse could trigger a fast cascade in either direction.

Momentum indicators are showing early signs of reaccumulation, but they’re not yet decisive. Traders are watching two key levels:

A breakout above near-term resistance, which could trigger trend continuation and revive the bullish narrative.A breakdown under the recent support shelf, which may open the gates to a deeper corrective slide before buyers reassert control.Bitcoin’s current structure closely resembles its earlier macro pattern but on a larger scale. After the Q4 2024 breakout, BTC formed an inverse curve, retraced toward its previous range, and consolidated before a major impulse. The market now shows a similar coiling phase, suggesting one final liquidity sweep toward $85,000 may be needed to reset leverage and refill buy-side demand. If this pattern repeats, Bitcoin remains positioned for a renewed breakout, reclaiming $100K and potentially extending toward $110K—a move more likely to unfold in early 2026.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

HumidiFi relaunches its token sale after bots captured WET supply, introducing a new token, protected contracts, and fair distribution plans.

Izabela Anna2 min read

5 December 2025, 01:16 PM

HumidiFi plans a fresh token sale after a coordinated bot attack captured the entire WET supply during its public launch. The team described the incident as a major setback for early supporters, who expected a fair distribution after months of community growth. 

The project built momentum from DeFi trading activity on Solana, yet the event revealed critical vulnerabilities in the initial sale process. Consequently, HumidiFi moved quickly to design a new plan that protects legitimate participants and restores confidence across its user base.

How the Snipe HappenedAccording to the team, the bot farm deployed thousands of funded wallets. Each wallet prepared an instruction to push funds into the DTF contract the moment the sale opened. Additionally, the setup allowed multiple instructions to execute within a single transaction bundle. 

Each bundle triggered four transactions, and each transaction activated six instructions. Consequently, every bundle pushed about 24,000 USDC into the sale and captured roughly 350,000 WET. Many bundles were sent at once, overwhelming the sale window and leaving genuine users without a chance to participate.

HumidiFi said the event exposed how sophisticated automation can exploit public sale designs. The team described the attack as a coordinated rush that drained the entire allocation before real users could react. Moreover, the moment intensified calls across Solana’s DeFi community for smarter contract structures that defend distribution fairness.

New Token, New Contract, New ApproachHumidiFi will now issue a new token. Supporters from the Wetlist and JUP staking groups will receive a pro-rata airdrop. The sniper wallets will not receive any allocation. 

Besides replacing the token, the team said it rebuilt the DTF contract with community protection as the priority. Temporal developers contributed to the redesign, and Osec completed an audit.

The project plans to reopen the public sale on Monday. The team expects the improved contract to prevent the same exploit. Additionally, HumidiFi aims to reassure its early community that their role remains central. The group also said it wants to demonstrate that DeFi 2.0 requires fairer access paths rather than faster bots.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Izabela Anna

Izabela Anna is a knowledgeable freelance journalist, who boasts over five years of experience covering the cryptocurrency market. Her tenure has seen her navigate through the ebbs and flows of multiple market cycles, giving her a deep understanding within. Her journalistic focus lies in dissecting price action dynamics, scrutinizing the on-chain landscape, and providing insights from a technical perspective, making her a trusted voice in the realm of cryptocurrency reporting.

Read more about

Latest Solana (SOL) News Today

TL;DR

An expert from the Council on Foreign Relations questions the narrative of Bitcoin as a store of value.
BTC’s integration with Wall Street creates new vulnerabilities and risks of financial contagion.
The case of MicroStrategy and its index review is an “overlooked risk” that could generate massive outflows.

An analysis from Wall Street, the global center of traditional finance, has raised alarms about the true role of Bitcoin in the world. While the focus of retail traders is on price action, figures like Rebecca Patterson, Senior Fellow at the Council on Foreign Relations, warn that the cryptocurrency’s growing interconnectedness with legacy markets is creating systemic vulnerabilities.

Patterson, in a conversation with Bloomberg, questioned whether investors truly understand the inherent risk of the pioneering crypto asset. Far from being a defensive instrument or an inflation hedge, the expert maintains that Bitcoin continues to show speculative signals.

According to the expert, the problem lies in labeling an immature asset as mature. Many still believe that BTC is a store of value, despite its historical volatility and high sensitivity to liquidity conditions. Patterson warns that this erroneous narrative can mislead buyers into thinking the asset offers protections it cannot reliably provide. For her, the primary identity of the asset has not changed: it remains a high-risk exposure with the potential for sharp reversals.

The New Channel for Bitcoin Contagion Risk to Traditional Markets
While previous crypto crises, such as FTX, were mostly confined to the digital market, Patterson stresses that the industry has built robust bridges to traditional finance. Corporate balance sheets tied to Bitcoin, publicly traded companies with huge crypto positions, and index funds indirectly connected to these firms represent a very different risk structure than what existed a few years ago.

She also mentioned MicroStrategy as an example that warrants urgent attention. Its upcoming MSCI index review, scheduled for January 15, could determine whether large passive funds maintain their allocation to the company. A possible exclusion would force automatic outflows, and due to MicroStrategy’s oversized ties to Bitcoin, the shock would extend beyond the stock itself. This type of exposure through index channels, Patterson suggests, is one of the most overlooked risks facing Bitcoin’s near-term outlook.

To conclude, the expert said that as more traditional players enter the crypto space, volatility does not decrease; in fact, it may intensify. Every new link between digital assets and mainstream markets increases the likelihood that turbulence in one arena spills into the other. She stated that the question for investors is no longer whether Bitcoin can move independently of the traditional system, but whether the traditional system can remain insulated from Bitcoin.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

After a brief moment of bullish performance in Bitcoin, the price experienced a sudden pullback due to a broader market shakedown, which caused BTC to revisit the $90,000 threshold. While this pullback has sparked a frenzy in the cryptocurrency community, on-chain data has revealed a shocking trend about the sudden pullback.

True Capitulation, Not A Routine Bitcoin Pullback
The market was rocked by a recent decline in the price of Bitcoin, but this pullback comes with an extra layer. Alphractal, an advanced investment and on-chain data analytics platform, has shed crucial insights about the decline using several key indicators to determine the unseen trend.

After carrying out its research, the on-chain platform revealed that the latest Bitcoin drop was not just another correction, but a clear instance of a capitulation event. This abrupt turnaround seems to have embodied all the characteristics of a full-scale capitulation event. These include an emotional flush-out when panic selling, forced liquidations, and intense dread came together in one dramatic moment.

Alphractal’s reading is backed by three major signals that rarely show up together, suggesting a pivotal moment for BTC. Such a trend may be the turning point that reshapes the short-term trajectory of the crypto king.

The first signal highlighted by the platform comes from the Bitcoin Hash Rate, which has witnessed a steady decline over the last 30 days. Presently, miners are turning off their machines, triggering heightened pressure on the ecosystem. When miners begin to lose money, it typically implies that the market might have reached its peak.

Another signal is coming from the BTC price drawdown. After a fast, violent drop, the metric is hitting extreme levels beyond the historical median. This is not just a technical drop, but it’s pain, triggered by forced selling and liquidation.

A Rare Trend And A Good Entry Opportunity
Finally, the last signal is the recent spike in active supply as those holding BTC for months or years have begun spending their coins. A behavior of this kind only unfolds when investors exhibit heightened caution, causing sentiment to drop. 

An interesting aspect about this trend is that when these 3 signals flash in unison, the Capitulation Oscillator tends to rise. This is a moment that nearly always denotes the conclusion of a downward trend or a leveling phase, as was the case in 2021.

Source: Chart from Alphractal on X
While it has played out in previous scenarios, it is not a guarantee of an immediate bottom. However, moments like these have historically been uncommon and frequently present opportunities that only occur once or twice every cycle, especially for those rooted in on-chain data.

Joao Wedson, the founder of Alphractal, also confirms these signals, which point to real capitulation. According to Wedson, the recent correction was the most severe capitulation event since 2022. 

Nonetheless, this has traditionally led to the formation of long accumulation regions before the price makes its next macro direction. In other words, Wedson noted that the highest probability scenario is that 2025 will end in a broad sideways range; a classic phase of accumulation or redistribution.

BTC trading at $92,054 on the 1D chart | Source: BTCUSDT on Tradingview.com
Featured image from Pngtree, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Fri, 5/12/2025 - 13:32

Dogecoin team celebrates adoption milestone for the first and largest meme cryptocurrency, Dogecoin (DOGE).

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

In a recent tweet, the Dogecoin team reacted to an adoption milestone for the first and largest meme cryptocurrency, Dogecoin (DOGE).

According to reports, Buenos Aires' "BA Cripto" policy package allows residents and businesses to settle city taxes and administrative fees using cryptocurrencies, including Dogecoin.

Reacting to the report, Dogecoin official X account tweeted "Doge is everywhere."

HOT Stories

Buenos Aires continues to position itself as a crypto hub. In November this year, Binance announced it had signed a collaboration agreement with the government of the city to promote safe and responsible cryptocurrency adoption.

Part of the agreement is an awareness initiative, "Live Crypto in Your City," launched by Binance and the city to inform residents about how cryptocurrencies work and how they can be used securely. The campaign highlights practical use cases for digital assets, helping more citizens experience crypto as a tool for empowerment.

This week, Vanguard Group, the world’s second-largest asset manager, announced its decision to allow ETFs and mutual funds that primarily hold cryptocurrencies to be traded on its platform, reversing a longstanding position.

Dogecoin priceDogecoin reversed a two-day rise on Dec. 4. The drop has entered its second day, with Dogecoin down 3.53% in the last 24 hours to $0.144 and down 4.25% weekly.

U.S. macroeconomic data and institutional developments influenced market sentiment and volatility at the start of the week. Vanguard opened access to crypto ETF trading for clients earlier this week, and Bank of America told institutional customers they may allocate 1%-4% of their portfolios to digital assets. The CME launched a VIX-style implied volatility index for Bitcoin futures, with other altcoins to follow.

However, momentum remains soft, with recovery attempts fading in a sign that liquidity is still thin above current levels.

Liquidation data reveals a total of $298 million over the past day across the crypto market, with nearly $218 million in long liquidations and $80.13 million in shorts.

Related articles